Related Experiment Videos
Balloon dacryocystoplasty: indications and contraindications
J Berkefeld1, J Kirchner, H M Müller
1Institute of Neuroradiology, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Radiology
|December 11, 1997
Summary
Balloon dacryocystoplasty (DCP) is effective for select nasolacrimal duct obstructions. Success is highest in focal stenoses, while inflammation and trauma are contraindications for this epiphora treatment.
Area of Science:
- Ophthalmology
- Otorhinolaryngology
Background:
- Severe epiphora can result from nasolacrimal duct (NLD) obstruction.
- Balloon dacryocystoplasty (DCP) is a minimally invasive technique for NLD obstruction.
Purpose of the Study:
- To define the indications and contraindications for balloon dacryocystoplasty (DCP).
Main Methods:
- Eighty-five patients with NLD obstruction underwent DCP using micro-guide wires.
- Success rates were evaluated clinically and dacryocystographically at 6 and 12 months.
- Correlated treatment outcomes with clinical and dacryocystographic findings.
Main Results:
- Recanalization success was 92% for focal stenoses/short occlusions.
- Overall recanalization rates were 66% for complete and 79% for partial obstructions.
- 12-month patency was 89-94% without predictors of recurrence; reobstruction rate was 46% with predictors.
Conclusions:
- Balloon dacryocystoplasty is indicated for select NLD obstructions, particularly circumscribed focal stenoses or occlusions.
- Active dacryocystitis, dacryocystolithiasis, and posttraumatic lesions are contraindications.
- DCP can achieve results comparable to surgery in carefully selected patients.